Bodal Chemicals profit doubles in FY26 on revenue growth, SGST incentive
Consolidated net profit jumps to ₹478 mn from ₹185 mn; board also approves sale of non-core unit.
What's new
- Net profit more than doubled to ₹478 mn from ₹185 mn in FY25.
- Improvement driven by revenue growth and one-time SGST incentive recognition.
- Board approved sale of non-core, inoperative unit; company says it's not substantial.
Why it matters
The sharp profit jump confirms the turnaround trajectory, but the one-time SGST component means sustainability is the key question. With prior quarterly trends already pointing to improvement, the market may have priced in much of this.
What we're watching
- Whether the non-core asset sale generates any meaningful cash inflow.
- If revenue growth can sustain without the one-time SGST support.
- Any strategic shift in capital allocation post-divestiture.
The full read
Bodal Chemicals' FY26 audited results show consolidated net profit more than doubling to ₹478 million from ₹185 million in FY25, powered by revenue growth and a one-time SGST incentive. The board also approved the sale of a non-core, inoperative unit, though the company downplays its materiality. The earnings improvement, while sharp, was not entirely unexpected given the trajectory of prior quarterly results. The spotlight now shifts to whether the core business can maintain momentum without the one-time boost and what the proceeds from the unit sale might mean for balance sheet strength.